Role of the beta2 adrenoceptor in mediating positive inotropic activity in the failing heart and its relation to the hemodynamic actions of dopexamine hydrochloride
- 11 August 1988
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 62 (5) , 46C-52C
- https://doi.org/10.1016/s0002-9149(88)80067-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Inhibition of Uptake1 by dopexamine hydrochloride in vitro)British Journal of Pharmacology, 1987
- Human renovascular effects of dopexamine hydrochloride: A novel agonist of peripheral dopamine and beta2-adreno-receptorsEuropean Journal of Clinical Pharmacology, 1987
- The haemodynamic and myocardial effects of dopexamine: a new beta 2‐ adrenoceptor and dopaminergic agonist.British Journal of Clinical Pharmacology, 1986
- Acute haemodynamic and metabolic effects of dopexamine, a new dopaminergic receptor agonist, in patients with chronic heart failure.Heart, 1985
- Dopamine receptors: applications in clinical cardiology.Circulation, 1985
- The effects of dopexamine on the cardiovascular system of the dogBritish Journal of Pharmacology, 1985
- Dopexamine: a novel agonist at peripheral dopamine receptors and β2‐adrenoceptorsBritish Journal of Pharmacology, 1985
- Left ventricular end-systolic wall stress-velocity of fiber shortening relation: A load-independent index of myocardial contractilityJournal of the American College of Cardiology, 1984
- Wall stress and patterns of hypertrophy in the human left ventricle.Journal of Clinical Investigation, 1975
- Left Ventricular Tension and Stress in ManCirculation Research, 1963